Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question: July

Staff  |  July 1, 2013

#Test your coding knowledge for subsequent infusions of infliximab

Coding Corner Answer: July Coding Challenge

Staff  |  July 1, 2013

Coding for a patient who gets subsequent infusions of infliximab

Practice Page: CMS Releases Updated Timeline for Meaningful Use

Staff  |  July 1, 2013

New final rule delays Stage 2 and makes changes to Stage 1

Rheumatology Drug Research Should Focus on Particular Groups of Patients

Deborah Levenson  |  July 1, 2013

An analysis of risks and benefits of drugs in specific types of patients will help rheumatologists provide better treatment

California Rheumatology Alliance 2013 Meeting: Rheumatologists Advised to Drop Prednisone Maintenance Therapy in Lupus Patients

Stephanie Cajigal  |  July 1, 2013

A systemic lupus erythematosus (SLE) disease expert emphasizes benefits of hydroxychloroquine, burst of steroid treatments

California Rheumatology Alliance 2013 Meeting: Aim for Remission in Rheumatoid Arthritis

Stephanie Cajigal  |  July 1, 2013

Early diagnosis and aggressive treatment of RA is key, expert says

California Rheumatology Alliance 2013 Meeting: The Future of Rheumatoid Arthritis

Stephanie Cajigal  |  July 1, 2013

Treatment for RA should involve targeting subclinical disease and reversing immune dysregulation, expert says

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Tech Talk: Rheumatologists Have Many Options for Providing Patient Education Online

Thomas R. Collins  |  July 1, 2013

Services to provide and maintain patient-education segments of physicians’ websites become more sophisticated

What Rheumatologists Need to Know About the Physician Payment Sunshine Act

Steven M. Harris, Esq.  |  July 1, 2013

The federal act mandates transparency within physician–industry relationship

  • « Previous Page
  • 1
  • …
  • 650
  • 651
  • 652
  • 653
  • 654
  • …
  • 816
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences